FPCG — Avem Health Partners Share Price
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 25.44% | ||
Return on Equity | 69.95% | ||
Operating Margin | 41.94% |
Financial Summary
Year End 30th Sep | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014E | 2015E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 39.09 | 1.08 | 6.71 | 16.19 | 19.39 | n/a | n/a | -8.14% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | +36.53 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Avem Health Partners, Inc. provides financial, technology, management, and capital solutions to hospitals in rural markets. The Company provides a range of hospital management services, such as medical staff, lab, imaging, pharmacy, human resources, financial planning, accounting, information technology, swing bed, revenue cycle, supply chain, facility engineering, compliance, infection control, marketing, case management, quality, and continuing education. It operates in rural communities.
Directors
- Sean Kirrane CEO (33)
- Adrian Reeder CFO (40)
- Todd Parker NED (47)
- William Houlihan IND (65)
- Robert Schwartz IND (72)
- Richardson Sells IND (64)
- Last Annual
- September 30th, 2013
- Last Interim
- June 30th, 2014
- Incorporated
- November 8th, 2000
- Public Since
- December 24th, 2001
- No. of Employees
- 186
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 9,829

- Address
- 14201 Wireless Way, Suite B-100, OKLAHOMA CITY, 73134
- Web
- https://avemhealth.com/
- Phone
- +1 4052460218
- Contact
- Karla Soto
- Auditors
- Whitley Penn LLP
Upcoming Events for FPCG
Similar to FPCG
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
Aesthetic Medical International Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 20:38 UTC, shares in Avem Health Partners are trading at $1,025.00. This share price information is delayed by 15 minutes.
Shares in Avem Health Partners last closed at $1,025.00 and the price had moved by over the past 365 days. In terms of relative price strength the Avem Health Partners share price has underperformed the S&P500 Index by -6.57% over the past year.
There is no consensus recommendation for this security.
Find out moreAvem Health Partners does not currently pay a dividend.
Avem Health Partners does not currently pay a dividend.
Avem Health Partners does not currently pay a dividend.
To buy shares in Avem Health Partners you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1,025.00, shares in Avem Health Partners had a market capitalisation of .
Here are the trading details for Avem Health Partners:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: FPCG
Based on an overall assessment of its quality, value and momentum Avem Health Partners is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Avem Health Partners. Over the past six months, its share price has outperformed the S&P500 Index by +3.51%.
As of the last closing price of $1,025.00, shares in Avem Health Partners were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Avem Health Partners PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1,025.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Avem Health Partners' management team is headed by:
- Sean Kirrane - CEO
- Adrian Reeder - CFO
- Todd Parker - NED
- William Houlihan - IND
- Robert Schwartz - IND
- Richardson Sells - IND